The healthcare burden of disease progression in Medicare patients with functional mitral regurgitation.

CONCLUSION: Treating FMR patients earlier in their clinical trajectory may prevent disease progression and reduce high rates of healthcare utilization and expenditures. PMID: 31104524 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31104524?dopt=Abstract

Source: Journal of Medical Economics - May 22, 2019 Category: Health Management Tags: J Med Econ Source Type: research